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Children with attention-deﬁcit/hyperactivity disorder (ADHD) have smaller volumes of total brain
matter and subcortical regions, but it is unclear whether these represent delayed maturation or
persist into adulthood. We performed a structural MRI study in 119 adult ADHD patients and 107
controls and investigated total gray and white matter and volumes of accumbens, caudate, globus
pallidus, putamen, thalamus, amygdala and hippocampus. Additionally, we investigated effects of
gender, stimulant treatment and history of major depression (MDD). There was no main effect of
ADHD on the volumetric measures, nor was any effect observed in a secondary voxel-based
morphometry (VBM) analysis of the entire brain. However, in the volumetric analysis a signiﬁcant
gender by diagnosis interaction was found for caudate volume. Male patients showed reduced right
caudate volume compared to male controls, and caudate volume correlated with hyperactive/
impulsive symptoms. Furthermore, patients using stimulant treatment had a smaller right hippo-
campus volume compared to medication-naïve patients and controls. ADHD patients with previous
MDD showed smaller hippocampus volume compared to ADHD patients with no MDD. While these data
were obtained in a cross-sectional sample and need to be replicated in a longitudinal study, the
ﬁndings suggest that developmental brain differences in ADHD largely normalize in adulthood.
Reduced caudate volume in male patients may point to distinct neurobiological deﬁcits underlying
ADHD in the two genders. Smaller hippocampus volume in ADHD patients with previous MDD is
consistent with neurobiological alterations observed in MDD.
& 2013 Elsevier B.V. and ECNP. All rights reserved.Elsevier B.V. and ECNP. All rights reserved.
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A.M.H. Onnink et al.3981. Introduction with ADHD and 231 typically developing children by theAttention-deﬁcit/hyperactivity disorder (ADHD) is one of
the most common psychiatric disorders in childhood and is
strongly persistent over time (Polanczyk et al., 2007). At
least 15% of affected children still meet full ADHD criteria
according to the DSM-IV in adulthood, and 40–60% remit only
partially (Faraone et al., 2006). The average prevalence of
adult ADHD is estimated to be between 2.5% and 4.9%
(Simon et al., 2009).
Magnetic Resonance Imaging (MRI) studies have reported
structural abnormalities in several regions of the brain in
patients with childhood ADHD compared to controls (see
meta-analyses by Ellison-Wright et al. (2008), Frodl and
Skokauskas (2012), Nakao et al. (2011), and Valera et al.
(2007)). However, there are inconsistencies across studies
and it is unclear which brain regions have the strongest
reduction of volumes or area compared to controls. An often
used strategy to overcome limitations of single studies is to
perform a meta-analysis. So far, four meta-analyses of
structural MRI studies have been published. The ﬁrst
restricted the analysis to childhood studies and pooled data
of 22 region of interest studies comparing 565 ADHD
children and 583 controls (Valera et al., 2007). The largest
reductions in ADHD compared to controls were found in the
cerebellar regions, the splenium of the corpus callosum,
total and right cerebral volumes and right caudate nucleus.
The second meta-analysis also focused on childhood studies
and included seven whole-brain voxel-based morphometry
(VBM) studies comparing 114 children with ADHD and 143
comparison subjects; the authors reported that ADHD was
associated with gray matter reductions in right putamen and
globus pallidus (Ellison-Wright et al., 2008).
An important question is whether brain abnormalities
observed in childhood ADHD persist into adulthood. In trying
to answer this question, two meta-analyses included pedia-
tric and adult ADHD samples to examine age effects on gray
matter volume using VBM. Nakao et al. (2011) included 202
children and adolescents, 176 adults with ADHD and 344
healthy controls, while Frodl and Skokauskas (2012) exam-
ined 175 children and adolescents and 145 adult patients
with ADHD, plus 288 healthy controls. Both studies con-
ﬁrmed ﬁndings from previous meta-analyses that volume
reductions of the right globus pallidus and putamen volumes
as well as the right and left volumes of the caudate were
the most consistent abnormalities in childhood ADHD. Using
meta-regression analysis, Nakao and colleagues further
showed that differences in gray matter volume in the right
putamen disappeared with increasing age suggesting nor-
malization in adulthood. An earlier cross-sectional study in
152 children and adolescents with ADHD and 139 age- and
sex-matched controls had also suggested normalization of
caudate volume throughout adolescence (Castellanos et al.,
2002). Along the same lines, a longitudinal study investigat-
ing cortical thickness in 223 ADHD children and 223 normally
developing children showed that the peak of cortical
thickness maturation was delayed in children with ADHD
compared with healthy peers by an average of 3 years, with
some regions, including frontal and temporal cortex areas,
being delayed in their maturation by up to 5 years (Shaw
et al., 2007). A recent longitudinal study in 234 childrensame group extended the previous ﬁnding by demonstrating
that maturation of cortical surface area was delayed in the
same way as cortical thickness was (Shaw et al., 2012).
However, neither of the longitudinal studies was able to
examine whether persistence of ADHD is related with brain
maturation, since most of their participants were still under
18 years and adult clinical outcome data were lacking for
the majority of subjects. Normalization may still only
concern the children/adolescents with ADHD who show
recovery in adulthood, because several structural neuroi-
maging studies in adult ADHD patients did observe differ-
ences compared to controls (Table 1). However, sample
sizes have been relatively small. So far, 13 studies have
been published with sample sizes ranging from 8 (Hesslinger
et al., 2002) to 74 ADHD patients (Seidman et al., 2011).
Three studies in adult ADHD patients show reductions in the
caudate nucleus (Almeida Montes et al., 2010; Proal et al.,
2011; Seidman et al., 2011). Additional volumetric reduc-
tions are found in putamen (Seidman et al., 2011), right
thalamus (Proal et al., 2011), dorso-lateral prefrontal
cortex (Biederman et al., 2008; Makris et al., 2007;
Seidman et al., 2011, 2006), left fronto-orbital cortex
(Hesslinger et al., 2002) and anterior cingulate cortex
(Amico et al., 2011; Biederman et al., 2008; Makris et al.,
2007), superior and inferior frontal gyrus (Almeida et al.,
2010; Depue et al., 2010; Seidman et al., 2006), early visual
cortex (Ahrendts et al., 2011), amygdala (Frodl et al., 2010)
and cerebellar regions (Biederman et al., 2008; Proal et al.,
2011; Seidman et al., 2011).
Taken together, the literature does not provide a clear
picture how abnormal childhood brain volumetrics translate
into adulthood. Moreover, it remains unclear what the role
of gender is in this developmental process. In childhood
ADHD, relatively more boys than girls are diagnosed with
ADHD, with male-to-female ratios ranging from 3:1 (Arnold,
1996) to as much as 9:1 (Gaub and Carlson, 1997). As an
unfortunate consequence, affected girls have been extre-
mely underrepresented in childhood neuroimaging studies
(Valera et al., 2007), and the studies that speciﬁcally
examined gender differences showed inconsistent ﬁndings.
Castellanos et al. (2002) showed that boys (n=89) and girls
(n=63) have relatively similar structural brain abnormal-
ities. In contrast, Qiu et al. (2009) examined the effects of
ADHD, gender and their interaction on basal ganglia volume
in 27 boys and 20 girls with ADHD and reported no
abnormalities in girls, while boys showed smaller volumes
of caudate, putamen and globus pallidus. In the meta-
analysis of Frodl and Skokauskas (2012), smaller right puta-
men volumes in childhood ADHD did not reach signiﬁcance
when gender was a covariate. This indicates that in child-
hood ADHD gender may indeed play a role. Compared to
childhood, the prevalence of ADHD in adults shows a more
balanced gender distribution (Biederman et al., 1994,
1993). Most structural neuroimaging studies of adult ADHD
included comparable numbers of males and females. Some
reported the absence of gender differences (Almeida
Montes et al., 2010; Seidman et al., 2011), but most studies
may have lacked power to adequately examine such differ-
ences because of their limited sample size.
A confounding factor to nearly all ADHD studies is medica-
tion use. Stimulants like methylphenidate are currently the
Table 1 Summary of study characteristics and results.
Study Subjects Gender
(% male)
Age ADHD:
range of M
(SD)
Analysis method Findings
Hesslinger
et al.
(2002)
8 ADHD, 17 HC 100 31.4 (4.4) Manual deﬁned ROI: orbital
frontal cortex
ADHDoHC, left orbital frontal
cortex
Seidman
et al.
(2006)
24 ADHD, 18 HC 50 38.0 (2.2) Manual parcellation of the
neocortex
ADHDoHC, dorsolateral,
prefrontal and anterior
cingulate cortex
Makris
et al.
(2007)
24 ADHD, 18 HC 50 38 (2.2) Cortical thickness ADHDoHC, right hemisphere:
inferior parietal lobule, the
dorsolateral prefrontal, and
the anterior cingulate cortices
Biederman
et al.
(2008)
26 ADHD, 23 HC, 18 BPD,
31 ADHD+BPD
50 36.9 (11.1) Manual parcellation of the
neocortex
ADHDoHC, neocortex, overall
frontal lobe and superior
prefrontal cortex, right
anterior cingulate cortex and
cerebellum
Perlov
et al.
(2008)
27 Adult, 27 HC 63 32.4 (10.6) Manual deﬁned ROI:
hippocampus and amygdala
ADHD=HC
Almeida
et al.
(2010)
21 ADHD children, 18
ADHD adolescents, 20
ADHD adults, 22 HC
children, 20 HC
adolescents, 20 HC
adults
50 28.95 (4.01) Cortical thickness Children, adolescents and
adult ADHDoHC, regions in
the right superior frontal gyrus
Depue
et al.
(2010)
30 ADHD, 20 HC 61 20.0 (1.7) VBM. Whole brain, ROI: the
superior parietal lobule, right
inferior frontal gyrus
ADHD=HC, whole brain.
ADHDoHC, right inferior
frontal gyrus
Frodl et al.
(2010)
20 ADHD, 20 HC, 20 MD 75 33.6 (10.2) Manual deﬁned ROI:
hippocampus and amygdala
ADHDoHC and MD, bilateral
amygdala
Montes
et al.
(2010)
20 ADHD, 20 HC 50 28.95 (4.01) VBM ADHDoHC, caudate
Ahrendts
et al.
(2011)
31 ADHD, 31 HC 65 31.20 (9.70) VBM ADHDoHC, visual cortex
Amico
et al.
(2011)
20 ADHD, 20 HC 75 33.6 (10.2) VBM. ROI: prefrontal cortex,
cingulate cortex, hippocampus
and amygdala
ADHD=HC, whole brain.
ADHDoHC, anterior cingulate
cortex
Proal et al.
(2011)
59 Childhood ADHD, 80
HC. 17 persistent ADHD,
26 remitted ADHD
100 41.1 (2.7) VBM and cortical thickness ADHDoHC, total cerebral
volume, global cortical
thickness, right caudate, right
thalamus, and bilateral
cerebellar hemispheres
Seidman
et al.
(2011)
74 ADHD, 54 HC 51 37.3 (12.6) VBM. Whole brain, ROI:
dorsolateral prefrontal cortex,
anterior cingulate cortex,
caudate, putamen, inferior
parietal lobule, and
cerebellum
ADHD=HC, whole brain.
ADHDoHC, dorsolateral
prefrontal cortex, anterior
cingulate cortex, caudate,
putamen, inferior parietal
lobule, and cerebellum
399Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depressionmost frequently prescribed medications for ADHD (Heal
et al., 2009), and are known to alter brain activity (Epstein
et al., 2007). Studies examining the effects of stimulants on
structural brain measures indicate that psychostimulants maynot have a severe effect on the brain. In children with ADHD,
no signiﬁcant differences in brain volumes were found
between medicated and treatment-naive children (Castellanos
et al., 2002). Other studies reported that chronic stimulant
A.M.H. Onnink et al.400treatment is associated with normal volumes of brain struc-
tures, such as right anterior cingulate and cerebellar vermis
(Bledsoe et al., 2009; Pliszka et al., 2006). Moreover, ADHD
adolescents not receiving treatment showed more rapid cortical
thinning compared with patients taking psychostimulants (Shaw
et al., 2009). Two recent meta-regression analyses reported
that stimulant use is associated with an absence of reductions
of regional gray matter volumes using VBM, suggesting a
normalizing effect of treatment on neural abnormalities
(Frodl and Skokauskas, 2012; Nakao et al., 2011).
Neuroimaging research addressing the effects of co-
morbidity between ADHD and major depressive disorder
(MDD) is scarce, even though MDD co-occurs with adult
ADHD in up to 50% of cases (McIntosh et al., 2009). There is
a strong evidence that MDD is related with structural brain
changes in the hippocampus and amygdala. Several meta-
analyses demonstrated a reduction in hippocampal volume
in patients relative to controls (Arnone et al., 2012; Cole
et al., 2011; Du et al., 2012; Kempton et al., 2011;
Koolschijn et al., 2009; Videbech and Ravnkilde, 2004).
For amygdala volume, a meta-analysis showed that only
unmedicated, and not medicated, depressed individuals
have decreased amygdala volume relative to healthy con-
trols (Hamilton et al., 2008). However, there is also
evidence that amygdala volume may be enlarged in acute
ﬁrst episode MDD (van Eijndhoven et al., 2009). So far, three
structural imaging studies examined current depression
severity in adult ADHD. Perlov et al. (2008) investigated
depression severity in a group of 27 patients and found a
correlation between enlarged amygdala volume and depres-
sive symptoms. Frodl et al. (2010) examined amygdala and
hippocampal volumes in 20 patients with ADHD, 20 matched
patients with MDD and 20 healthy controls. Hippocampal
volumes were unaltered in ADHD patients and although
patients had smaller amygdala volumes compared with the
other groups, they demonstrated that higher rates of
depressive symptoms in ADHD patients were related with
larger amygdala volumes. Amico et al. (2011) studied
depression severity in a sample of 20 ADHD adults, but
found no correlation with structural alterations. In sum, the
limited literature investigating depressive symptoms in
ADHD does not support evidence for smaller hippocampal
volume, and two studies suggest that larger amygdala
volume is associated with higher current depression scores
(Frodl et al., 2010; Perlov et al., 2008).
To shed more light on the issues discussed above, we
investigated a large sample of 119 adult ADHD patients and
107 healthy comparison subjects. We were particularly
interested in subcortical gray matter structures, which have
been consistently found to be altered in persistent ADHD.
This is in line with the hypothesis of Halperin and Schulz
(2006), which provides a neurodevelopmental model for
ADHD persistence proposing that the disorder is caused by
non-cortical neural dysfunction that is present early in life
and remains relatively stable throughout the lifetime,
potentially compensated by prefrontal cortex function in
remitting forms of ADHD. We used the automated FSL FIRST
subcortical segmentation tool to compare regional volu-
metric data for a range of deep gray matter structures.
A reduced caudate nucleus volume is one of the most
consistent ﬁndings in childhood literature (Frodl and
Skokauskas, 2012; Nakao et al., 2011; Valera et al., 2007),and while some studies suggest that this volume difference
may disappear during adolescence (Ahrendts et al., 2011;
Amico et al., 2011; Carmona et al., 2005; Castellanos et al.,
2002; Depue et al., 2010), several studies still ﬁnd reduced
caudate volume in adult ADHD patients (Almeida Montes
et al., 2010; Proal et al., 2011; Seidman et al., 2011).
Moreover, caudate volume was found to be signiﬁcantly
smaller in patients in the largest MRI study performed in
adult ADHD to this date (n=74). The results from Proal et al.
(2011) nicely support the hypothesis by Halperin and Schulz
by showing that caudate volume differences were present
independent of whether ADHD persisted or remitted. Based
on this evidence, we hypothesized that caudate volume
differences are still present in adults with ADHD. In addi-
tion, we explored other brain structures for differences
between patients and controls and the role of gender
herein, expecting structural differences to be less pro-
nounced in females than in males (Frodl and Skokauskas,
2012; Qiu et al., 2009). For differences observed, we
explored their clinical relevance for symptom severity in
ADHD. To test for additional regions of altered gray matter
volume between patients and controls not captured by FSL
FIRST, we also performed a voxel-based morphometry (VBM)
analysis of the entire brain. We subsequently examined
stimulant treatment effects on the subcortical brain
volumes expecting to ﬁnd that treatment-naive patients
show smaller brain volumes as compared to patients taking
medication (Frodl and Skokauskas, 2012; Nakao et al.,
2011). Lastly, effects of a history of MDD in ADHD were
investigated, since our sample contained enough ADHD
patients diagnosed with previous MDD to reach an adequate
sample size. Here, we focused on hippocampal and amyg-
dala volumes for their known importance in depression. We
expected smaller hippocampal volume in patients with a
history of MDD (Arnone et al., 2012; Cole et al., 2011; Du
et al., 2012; Kempton et al., 2011; Koolschijn et al., 2009;
Videbech and Ravnkilde, 2004). Since we collected no
information on current depression, we tested amygdala
volume differences in an exploratory fashion.
2. Experimental procedures
2.1. Participants
228 Individuals (119 adult ADHD patients, 107 healthy comparison
subjects) from the Dutch cohort of the International Multicentre
persistent ADHD CollaboraTion, IMpACT (Franke et al., 2010a),
participated in this study. The ADHD patients and the age-,
gender-, and IQ-comparable group of healthy comparison subjects
were recruited from the department of Psychiatry of the Radboud
University Nijmegen Medical Centre and through advertisements.
For the analyses of stimulant treatment effects, we split the ADHD
group into a group of medication naive patients and a group of
patients receiving stimulant treatment. Eight ADHD subjects receiv-
ing atomoxetine and 13 patients who had previously received
medication and had stopped medication well before testing were
excluded from this part of the analysis.
Patients were included if they met DSM-IV-TR criteria for ADHD in
childhood as well as adulthood. All participants were assessed using
the Diagnostic Interview for Adult ADHD (DIVA) (Kooij, 2010). This
interview focuses on the 18 DSM-IV symptoms of ADHD and uses
concrete and realistic examples to thoroughly investigate whether a
symptom is currently present or was present in childhood. In order to
401Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depressionobtain information about ADHD symptoms and impairment in child-
hood, additional information was acquired from parent and school
reports, whenever possible. The Structured Clinical Interview for DSM-
IV (SCID-I & SCID-II) (Groenestijn et al., 1999; Weertman et al., 2000)
was used for comorbidity assessment. Assessments were carried out by
trained professionals (psychiatrists or psychologists). In addition, a
quantitative measure of clinical symptoms was obtained using the
ADHD-DSM-IV Self-Rating scale (Kooij et al., 2005).
Exclusion criteria for participants were psychosis, alcohol or
substance use disorder in the last 6 months, current major depres-
sion, full-scale IQ estimate o70 (prorated from Block Design and
Vocabulary of the Wechsler Adult Intelligence Scale-III), neurologi-
cal disorders, sensorimotor disabilities, non-Caucasian ethnicity,
and medication use other than psychostimulants or atomoxetine.
An additional exclusion criterion for the healthy comparison sub-
jects was a current neurological or psychiatric disorder according to
SCID-I. This study was approved by the regional ethics committee.
Written informed consent was obtained from all participants.2.2. MRI acquisition and data processing
T1-weighted images were acquired using a 1.5 T MRI scanner
(Sonata Siemens, Munich, Germany) at the Donders Centre for
Cognitive Neuroscience. All scans covered the entire brain and had
a voxel size of 1 1 1 mm3, TR 2730 ms, TI 1000 ms, TE 2.95 ms,
176 sagittal slices, ﬁeld of view 256 mm.
For automatic segmentation of subcortical brain structures,
the FIRST module (version 1.2) of FSL (version 4.1) was used
(www.fmrib.ox.ac.uk/fsl/ﬁrst/index.html). This method is based
on Bayesian statistical models of shape and appearance for 17
subcortical structures from 317 manually labeled T1-weighted MR
images. To ﬁt the models, the probability of the shape given the
observed intensities was used (Smith et al., 2004). In addition, to
model intensity at the structural boundary, automatic boundary
correction was applied. The scan–rescan reliability of FSL derived
volumes is about 0.9 or higher for large structures such as the
thalamus and caudate, but is smaller (0.6) for smaller structures
such as the accumbens, pallidum and amygdala (Morey et al., 2010;
Narayana et al., 1988). After automatic segmentation, volume
determination of the subcortical structures was calculated using a
script in Matlab7.2 (MathWorks, USA). In this script the volumes of
the regional structures of interest were calculated by multiplying
the number of voxels with the voxel volume (1 mm3). Inspection of
the segmented subcortical structures projected onto the
T1-weighted MRI scans was performed using the software MRIcroN
Version Beta 7 (www.mricro.com/mricron) to detect obvious seg
mentation errors.
Whole brain segmentation of gray matter, white matter and
cerebrospinal ﬂuid (CSF) was performed using the VBM8 toolbox in
SPM8. Total volume of gray and white matter was calculated by
adding the resulting tissue probability maps. Total brain volume was
deﬁned as the sum of white and gray matter volume.
A post-hoc VBM analysis was performed using SPM8 (http://www.
ﬁl.ion.ucl.ac.uk/spm) and Matlab7.2 (MathWorks, USA). Images
were segmented into gray matter, white matter and CSF using the
standard uniﬁed segmentation model in SPM8 (Ashburner and
Friston, 2005). Gray matter population templates were generated
from the entire image dataset using the diffeomorphic anatomical
registration using exponentiated Lie algebra (DARTEL) technique
(Ashburner, 2007). After an initial afﬁne registration of the gray
matter DARTEL templates to the tissue probability maps in Montreal
Neurological Institute (MNI) space (http://www.mni.mcgill.ca/),
non-linear warping of gray matter images was then performed to
the DARTEL gray matter template in MNI space. Subsequently
images were modulated to ensure that relative volumes of gray
matter were preserved following the spatial normalization proce
dure. Lastly, images were smoothed with an 8 mm full width at halfmaximum Gaussian kernel. After spatial pre-processing, the
smoothed, modulated, normalized gray matter datasets were used
for statistical analysis (absolute threshold: 0.2).2.3. Statistical analysis
Data were analyzed using the Statistical Package for the Social
Sciences (SPSS) version 20 (SPSS, Inc., Chicago, IL). Differences for
total gray and white matter were tested with separate general
linear models (GLM) with diagnosis and gender as ﬁxed factors. Age
and total white matter volume (when correcting for gray matter)
and total gray matter volume (when correcting for white matter)
were included in the model as co-variates. To compare volumetric
data of our regions of interests (left and right nucleus accumbens,
amygdala, caudate nucleus, hippocampus, globus pallidus, putamen
and thalamus), a GLM was used in which the volumes were included
as dependent factors. Diagnosis (healthy comparison subjects vs.
ADHD patients), treatment (healthy comparison subjects vs. ADHD
naive vs. ADHD stimulant-medicated) and depression history (ADHD
patients with no history of depressive episodes vs. ADHD patients
with one or more episodes in the past) were added as between
subject factors. For each between-subject factor, a separate GLM
analysis was used. For all the GLM analyses, age and total brain
volume were included in the model as co-variates and gender was
added as ﬁxed factor to investigate interaction effects. Whenever
this interaction term was signiﬁcant at α=0.05, we analyzed the
results separately by gender. The relation between total number of
self-reported ADHD symptoms and right caudate volume in male
patients was studied using linear regression analysis adjusting for
age and total brain volume. To explore effects of the distinct ADHD
symptom domains, a similar analysis was performed including either
inattentive symptom count or hyperactivity/impulsivity symptom
count as an independent variable. Signiﬁcance between subject
ﬁndings was explored using linear regression analysis to investigate
the relation between volume and duration of medication use
(in months) adjusting for age and total brain volume. Because data
for the rating scale scores and duration of medication use were
highly positively skewed, prior to the regression analyses, a
logarithmic transformation was conducted because data for the
rating scale scores and duration of medication use were highly
positively skewed. All statistical tests were two-sided, unless stated
otherwise. As we hypothesized smaller caudate nucleus volume in
ADHD and smaller hippocampus volume in former depressed ADHD
patients, we performed a one-sided test and did not correct for
multiple testing for these structures. All other tests were corrected
for multiple testing. This correction consisted of adjusting p-values
based on the false discovery rate (FDR) controlling procedure with a
p-value of less than 0.05 (Benjamini and Hochberg, 1995).
For the post-hoc VBM analysis, group differences in absolute gray
matter volume were assessed using a full-factorial ANCOVA with
diagnosis and gender included as factors and participants' age and
total brain volume added to the model as covariates. The FDR
correction for multiple comparisons was used with a p-value of less
than 0.05. The extent threshold was set at 10 voxels, to eliminate
very small clusters.
3. Results
A total of 119 adult ADHD patients and 107 healthy
comparison subjects were included in the analysis. The
demographics for this sample are summarized in Table 2.
There were no signiﬁcant differences in age and estimated
IQ between patients and controls (p40.05), and sex ratio
did not signiﬁcantly differ between the two groups
(χ2=0.25, p=0.68). Group-by-sex ANOVAs showed group
Table 2 Demographic characteristics of ADHD patients and healthy comparison subjects.
Variable Total group Males Females
HC (n=107) ADHD
(n=119)
HC (n=45) ADHD (n=46) HC (n=62) ADHD (n=73)
Age 36.92711.54 36.29710.90 36.02711.06 37.72710.47 37.56711.92 35.40711.14
Esitmated IQa 110.21715.35 107.49714.69 112.11714.68 106.57714.11 108.84715.79 108.07715.11
Inattentive symptomsb 0.6271.12 6.4372.06 1.0271.39 6.8772.06 0.3270.76 6.1572.03
Hyperactive/impulsive
symptomsb
0.8271.29 5.6072.24 1.1171.56 5.6372.09 0.6171.01 5.5872.35
N N N N N N
One or more depressive
episode (remitted)c
11 (10%) 55 (46%) 6 (13%) 17 (37%) 5 (9%) 38 (52%)
Bipolar (remitted)c 0 8 (7%) 0 3 (7%) 0 5 (7%)
Anxiety disorder (remitted)c 7 27 (23%) 4 (9%) 7 (15%) 3 (5%) 20 (27%)
Substance abuse (remitted)c 8 22 (18%) 7 (16%) 17 (36%) 1 (2%) 5 (7%)
Borderlinec 0 10 (8%) 0 2 (4%) 0 8 (11%)
Antisocialc 0 3 (3%) 0 2 (4%) 0 1 (1%)
Medication-naive – 16 (13%) – 9 (20%) – 7 (10%)
On stimulant medication – 82 (69%) – 29 (61%) – 53 (74%)
Medication in the past – 13 (11%) – 6 (13%) – 7 (10%)
On atomoxetine – 8 (7%) – 2 (4%) – 6 (8%)
Demographic information representing mean7standard deviations or percentage per group. HC=healthy comparison subject.
aProrated from Block Design and Vocabulary of WAIS-III-R.
bAs measured with the ADHD-DSM-IV Self-Rating scale (Kooij et al., 2005).
cAs measured by the Structured Clinical Interview for DSM-IV for axis I (Groenestijn et al., 1999) and axis II (Weertman et al., 2000)
disorders.
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tion (F(1, 222)=673.33, p40.001) and hyperactivity/impul-
sivity symptoms (F(1, 222)=354.17, p40.001) and sex
effect for number of symptoms for inattention (F(1, 222)
=9.94, p=0.002) but no interactions. The subjects with
ADHD had higher number of self-reported symptom of
inattention and hyperactivity/impulsivity and the women
had higher number of self-reported symptoms for inatten-
tion. There were no signiﬁcant differences in sex ratio and
age and estimated IQ was not different between healthy
comparison subjects, ADHD naive and ADHD stimulant-
medicated patients (p40.05). The groups differed on
symptoms for inattention and hyperactivity/impulsivity
symptoms (F(2, 199)=344.26, p40.001; F(2, 199)
=192.51, p40.001). On both scales, healthy comparison
subjects, showed lower number of symptoms than ADHD
naive and ADHD stimulant-medicated. There were no sig-
niﬁcant differences in age, estimated IQ between and
number of symptoms for inattention and hyperactivity/
impulsivity symptoms between ADHD patients with one or
more episode in the past and no history of depressive
episodes (p40.05). The group ADHD patients with one or
more episode in the past contained more females than the
group ADHD patient with no history of depressive episodes
(χ2=3.94, p=0.047).
Comparison of the volumes of caudate nucleus between
patients and controls showed no main effect of diagnosis on
volume (Table 3). However, when probing caudate volumes for
interaction effects of ADHD diagnosis and gender, right caudatevolume showed a signiﬁcant interaction effect (F(1, 220)=5.84,
p=0.016, partial eta squared=0.026). Separate post-hoc ana-
lyses for both genders indicated that right caudate volume was
signiﬁcantly smaller in male ADHD patients (F(1, 87)=7.14,
pone-sided=0.005, partial eta squared=0.076), while this was not
the case in females (F(1, 131)=0.55, pone-sided=0.23, partial eta
squared=0.004). Results for the analysis of the volumes of
nucleus accumbens, amygdala, hippocampus, globus pallidus,
thalamus, and total white and gray matter are summarized in
Table 3. No differences between ADHD patients and healthy
subjects were observed for total brain volume, gray matter or
white matter volume. In addition, none of the other subcortical
brain volumes nor hippocampus volume differed signiﬁcantly.
Taking gender into account did not change these results. A post-
hoc, whole-brain, voxel-by-voxel examination comparing the
subjects and controls did not reveal any areas with signiﬁcant
gray matter differences, nor was there no signiﬁcant effect of
diagnosis gender interaction (po0.05, FDR corrected).
In the male ADHD patients, a linear regression analysis
showed right caudate volumes were signiﬁcantly associated
with the total number of ADHD symptoms (β=0.35,
p=0.011). Post-hoc analysis indicated that the association in
the right caudate was primarily due to an effect on hyperac-
tive/impulsive (β=0.42, p=0.002) rather than inattentive
(β=0.15, p=0.30) symptoms. In Figure 1, the relationship
between right caudate volume and symptom rates is shown.
In a more exploratory design, we tested the effect of
stimulant treatment. As shown in Table 4, stimulant treatment
was associated with volumes of the right amygdala (F(2, 197)
Table 3 Bilateral and total volumes (ml)7standard error for ADHD patients (ADHD) and healthy comparison subjects (HC)
based on the estimated marginal means and controlled for age, gender and total brain volume. Volumes are also shown for
males (M) and females (F), separately.
HC (n=107) HC M (n=45) HC F (n=62) ADHD (n=119) ADHD M (n=46) ADHD F (n=73)
L CDN 2.6070.03 2.7470.04 2.5170.03 2.5770.02 2.6570.04 2.5170.03
R CDN 2.6970.03 2.8870.04 2.5670.03 2.6570.02 2.7470.04 2.5970.03
L ACC 0.3470.01 0.3770.01 0.3370.01 0.3470.01 0.3770.01 0.3370.01
R ACC 0.3770.01 0.4070.01 0.3670.01 0.3670.01 0.3870.01 0.3570.01
L AMY 1.1170.01 1.1970.02 1.0670.02 1.1070.01 1.2070.02 1.0470.02
R AMY 1.0970.01 1.1870.02 1.0270.02 1.1070.01 1.2170.02 1.0470.02
L HIPP 2.7670.03 2.9770.04 2.6270.03 2.7770.02 2.9270.04 2.6670.03
R HIPP 2.6970.02 2.8570.04 2.5770.03 2.6670.02 2.8070.04 2.5770.03
R GP 0.9270.01 1.0070.01 0.8670.01 0.9270.01 0.9970.01 0.8870.01
L GP 0.9670.01 1.0270.01 0.9170.01 0.9670.01 1.0370.01 0.9170.01
L PUT 3.0170.03 3.2570.04 2.8470.04 3.0270.03 3.2270.04 2.8870.03
R PUT 3.0670.03 3.3170.05 2.8870.04 3.0170.03 3.2170.04 2.8970.04
L THA 5.4370.03 5.7070.05 5.2570.04 5.4370.03 5.7070.05 5.2570.04
R THA 5.7770.03 6.0670.05 5.5670.04 5.7170.03 5.9770.05 5.5470.07
GRAY 732.6175.25 774.1278.40 705.0276.75 737.5374.98 771.3178.31 714.0876.22
WHITE 504.1774.19 537.3577.02 482.0075.19 508.9373.97 536.3276.94 490.0674.78
HC: healthy controles; ADHD: ADHD patients; M: males; F: females; L: left; R: right; CDN: caudate; ACC: accumbens; AMY: amygdala;
HIPP: hippocampus; GP: globus pallidus; PUT: putamen; THA: thalamus; T BRAIN: total of white and gray matter; GRAY: volume of gray
matter; WHITE: volume of white matter. Bold indicates results at po0.05.
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left and right caudate (left: F(2, 197)=3.28, p=0.040,
padj=0.128, partial eta squared=0.031; right: F(2, 197)
=3.13, p=0.046, padj=0.122, partial eta squared =0.031), left
globus pallidus (F(2, 197)=3.84, p=0.023, padj=0.122, partial
eta squared=0.037), right putamen (F(2, 197)=4.28, p=0.015,
padj=0.120, partial eta squared=0.041) and right hippocampus
(F(2, 197)=6.31, p=0.002, padj=0.042, partial eta squared=
0.060). The effect on right hippocampus volume survived
multiple comparisons correction. Post-hoc tests revealed that
patients using stimulant treatment had a smaller right hippo-
campus volume compared to medication-naïve patients
(p=0.001) and controls (p=0.016). A linear regression showed
that right hippocampus volume was not associated with dura-
tion of stimulant use (β=0.09, p=0.333).
As shown in Table 1, 46% of the ADHD patients had had one
or more depressive episodes in the past. A comparison
between ADHD patients with and without a history of MDD
revealed signiﬁcantly smaller left hippocampus volume in
ADHD patients with at least one past depressive episode
(F(1, 108)=5.21, pone-sided=0.012, partial eta squared=0.043),
but no effects on amygdala volumes (Table 5).4. Discussion
In the present study, we investigated total, subcortical and
hippocampal brain volumes in a sample of 119 adult ADHD
patients and 107 healthy comparison subjects. The analyses
of regional brain volumes were all adjusted for total brainvolume. Our hypothesis of smaller caudate volume in adult
ADHD was conﬁrmed, though the right caudate volume was
only smaller (relative to brain size) in male patients. This
gender effect was consistent with our hypothesis that
structural differences are less pronounced in females than
in males. We demonstrated in addition, that the reduction
in the caudate was correlated with severity of the illness,
with a smaller caudate being associated with more ADHD
symptoms (primarily hyperactive/impulsive symptoms).
We found no reduction of total gray or white matter volume
in patients compared to healthy comparison subjects, nor
were any of the other subcortical brain volumes or hippo-
campus volume affected. In the VBM analysis, no additional
differences in cortical gray matter volume were observed
between adult patients and controls either. Patients using
stimulant treatment had a smaller right hippocampus
volume compared to medication-naïve patients and con-
trols. ADHD patients with a lifetime history of MDD showed a
smaller volume of left hippocampus compared with ADHD
patients having no earlier episodes of MDD. Effect sizes
(given as partial eta-squared) for the observed effects
ranged from 0.043 (for hippocampus volume in depression)
to 0.06 (for hippocampus volume in stimulant users) and
0.076 (for caudate nucleus ﬁnding in ADHD males), which
means that the effect sizes were small to modest.
The fact that only few differences between adult
patients and controls were found is in line with hypotheses
of developmental delay and normalization of brain structure
in adulthood (Shaw et al., 2007, 2012). Our ﬁnding of an
absence of total brain (sum of gray and white matter)
Figure 1 (A–C) Association between the volume of the right caudate in male ADHD patients and number of total, inattentive and
hyperactive/impulsive symptoms on the ADHD-DSM-IV Self-Rating scale. The dots represent individual volumes and the solid line
represents the linear ﬁt.
A.M.H. Onnink et al.404volume differences is a common ﬁnding in ADHD (Biederman
et al., 2008; Hesslinger et al., 2002; Perlov et al., 2008;
Seidman et al., 2006). The absence of total brain volume in
our sample was not reﬂected by an imbalance between
white and gray matter as found by Seidman et al. (2006),
nor was it related to an effect of stimulant treatment as
reported by Castellanos et al. (2002).
Whereas cortical brain volume seems to normalize, we
conﬁrm prior evidence that smaller caudate volume is
persistent in ADHD (Almeida Montes et al., 2010; Proal
et al., 2011; Seidman et al., 2011). Moreover, the current
results extend these studies by showing that caudate
volume phenotype might be a gender-speciﬁc effect only
observed in males with ADHD. This is in line with a study in
children showing smaller basal ganglia volumes only in
ADHD boys (Qiu et al., 2009). In addition, our study shows
that caudate volume reduction in male patients is asso-
ciated with ADHD symptoms, with higher hyperactive/
impulsive ratings linked to smaller volume in the right
caudate. The association with hyperactive/impulsive rat-
ings with caudate volume is consistent with the literature
that the caudate is part of the extrapyramidal motor
system and plays an important role in locomotor control
(Ferris, 1972; Rebec, 2006). Furthermore, a study in ADHD
children showed that task performance on a response
inhibition task is positively associated with caudate volume
(Casey et al., 1997). While there seems to be a link with
symptom levels, the link with disease persistence is less
clear. The normalization of caudate volume in ADHD bylate adolescence as shown in the longitudinal study of
Castellanos et al. (2002) seems parallel to the reported
reduction of overt hyperactivity during adolescence
(Biederman et al., 2000; Hill and Schoener, 1996). Indeed,
we also ﬁnd that the reduction of caudate volume is
correlated with impulsive/hyperactive symptoms in male
adult patients, which suggests that persistence of overt
hyperactivity might be related to persistent volume reduc-
tions of the caudate. On the other hand, Proal et al. (2011)
investigated structural differences between ADHD remit-
ters and persisters and found that, among other regions, a
reduced right caudate volume was present in patients
independent of whether they had persistent ADHD or had
remitted. This ﬁnding is in line with the hypothesis of
Halperin and Schulz (2006) that subcortical dysfunction
that manifests early in life, remains static throughout the
lifetime, and is not associated with the remission of
symptomatology.
Although male and female adults with ADHD have similar
phenotypic features in terms of symptom ratings and co-
morbidity patterns (Biederman et al., 2004), the gender-
speciﬁc ﬁnding for caudate nucleus volume suggests that
partially distinct neurobiological deﬁcits underlie ADHD in
males and females. At the neurocognitive level, there is
evidence that adolescent males with ADHD show more
impaired inhibition than female patients (Rucklidge,
2006). Interestingly, the caudate nucleus is involved in
impulse inhibition in a sex-speciﬁc manner, as shown by a
recent study in healthy subjects (Liu et al., 2012). During a
Table 4 Bilateral and total volumes (ml)7standard error for healthy comparison subjects (HC), stimulant-naive ADHD
patients (ADHD naive: medication for r1 month) and stimulant-medicated patients (ADHD medicated: stimulant treatment
for 41 month) based on estimated marginal means and controlled for age, gender and total brain volume.
HC (n=107) ADHD naïve (n=16) ADHD stimulant-medicated (n=82)
L ACC 0.3570.01 0.3770.01 0.3470.01
R ACC 0.3770.01 0.3770.01 0.3670.01
L AMY 1.1270.01 1.1470.04 1.1270.02
R AMY 1.1070.01 1.2070.04 1.1070.02
L CDN 2.6170.03 2.6970.07 2.5370.03
R CDN 2.7170.03 2.7570.07 2.6270.03
L HIPP 2.7870.03 2.8270.07 2.7570.03
R HIPP 2.7070.02a 2.8370.06a 2.6170.03a
L GP 0.9670.01 1.0170.02 0.9570.01
R GP 0.9370.01 0.9670.02 0.9270.01
L PUT 3.0370.03 3.1470.07 2.9970.03
R PUT 3.0970.03 3.1770.08 2.9770.04
L THA 5.4570.03 5.5570.08 5.4470.04
R THA 5.7870.03 5.9070.09 5.6970.04
GRAY 738.1374.17 744.08710.75 741.1474.9
WHITE 508.4273.29 509.1778.49 510.7973.90
HC: healthy controls; ADHD: ADHD patients; L: left; R: right; ACC: accumbens; AMY: amygdala; CDN: caudate; HIPP: hippocampus; GP:
globus pallidus; PUT: putamen; THA: thalamus; T BRAIN: total of white and gray matter; GRAY: volume of gray matter; WHITE: volume
of white matter. Bold indicates results at po0.05.
aIndicated signiﬁcance after multiple testing.
Table 5 Bilateral and total hippocampus volumes (ml)
7standard error for ADHD patients with no MDD history
(ADHD ) and ADHD patients remitted from one or more
episodes of MDD (ADHD +) based on estimated marginal
means and controlled for age, gender and total brain
volume.
ADHD depression
 (n=54)
ADHD depression
+ (n=53)
L HIPP 2.8170.03 2.7170.04
R HIPP 2.7070.03 2.6270.04
L AMYG 1.1270.02 1.1070.02
R AMYG 1.1370.02 1.0970.02
ADHD depression : ADHD patients with no MDD history;
ADHD depression +: ADHD patients remitted from one or
more MDD; L: left, R: right; HIPP: hippocampus. Bold
indicates results at po0.05.
405Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depressionstop task, activation of the caudate nucleus and putamen in
males was positively correlated with task performance.
Females showed a positive correlation in the right inferior
temporal gyrus, while activation of the precuneus was
negatively correlated with task performance. A better
understanding of sex differences in brain anatomy and
activity would improve our understanding of the basis fordifferent neurocognitive proﬁles (such as impulse inhibition)
in males and females with ADHD. In that respect, an fMRI
study in ADHD looking speciﬁcally at gender differences
reported that ADHD males, but not ADHD females, showed
signiﬁcantly altered patterns of neural activity during a
verbal working memory task (Valera et al., 2010). Impor-
tantly, the results from MRI studies in childhood
ADHD, which mostly included boys, need to be considered
with caution since ﬁndings may not generalize to both
genders.
The VBM analysis did not pick up the gender-speciﬁc
effect on right caudate found with FSL FIRST. This is likely
due to the fact that the reduction is dispersed across the
entire caudate nucleus, with small effects, below detection
limit, on individual voxels measured in VBM.
Patients using stimulant treatment had a smaller right
hippocampus volume compared to medication-naïve patients
and controls. This unexpected ﬁnding is not in line with a
meta-analysis suggesting that untreated children have addi-
tional structural reductions compared with children receiving
treatment (Frodl and Skokauskas, 2012). There was no effect
of duration of stimulant medication use on the right hippo-
campus volume, which makes it difﬁcult to draw ﬁrm
conclusions regarding the effect of long term use of stimu-
lants in adult ADHD.
In the present study we also investigated the effects of
the most frequent co-morbidity of adult ADHD, i.e. MDD, on
brain structure. Observing smaller volumes of total and left
hippocampus in ADHD subjects with a history of MDD is in
A.M.H. Onnink et al.406line with well-studied reductions in hippocampal volume in
patients with current and recurrent depression (Arnone
et al., 2012; Cole et al., 2011; Du et al., 2012; Kempton
et al., 2011; Koolschijn et al., 2009; Videbech and
Ravnkilde, 2004). Previous ﬁndings suggested that depres-
sion severity in ADHD adults had no effect on hippocampal
volumes (Frodl et al., 2010). In this previous study, depres-
sion severity had been measured using a self-report measure
of current MDD symptoms, whereas we used a clinical
retrospective diagnosis of past MDD episodes. This is a
possible explanation for the conﬂicting results, while there
are indications that hippocampal volume may decrease at
the greatest rate early after MDD onset (MacQueen et al.,
2003). Further studies are clearly needed to fully
elucidate the link between MDD and structural brain
changes in ADHD.
The results of this study should be considered in the context
of some strengths and limitations. Our MRI study sample is the
largest one published to date for clinically diagnosed adult
ADHD, a clear strength of this work. Because our main
hypotheses were based on caudate nucleus and hippocampus
volumes, we chose to use FSL FIRST, which is known to be a
reliable tool for the automated segmentation of subcortical
structures (Morey et al., 2010; Narayana et al., 1988) and is
successfully used in other studies (De Jong et al., 2008; Franke
et al., 2010b; Narayana et al., 1988; Rijpkema et al., 2012;
Seror et al., 2010). Certain localized changes in subcortical
structures can also be detected using voxel-based morphometry
(VBM), but is more sensitive to inaccuracies of tissue-type
classiﬁcation and arbitrary smoothing extents (Patenaude
et al., 2011). Due to the poor and variable intensity contrast,
VBM might be more prone to registration artifacts in the deep
gray matter (Bookstein, 2001). Additionally, Frodl and
Skokauskas (2012) suggested that changes in smaller regions
like the amygdala and hippocampus might be more difﬁcult to
detect with VBM when large cluster threshold corrections for
the whole brain are used. Although, besides the volumes of
subcortical structures, we were interested in cortical gray
matter volume. We therefore performed a whole brain VBM
which is not biased towards a priori hypothesized regions
(Friston et al., 2006) which additionally increases comparability
with previous research.
This study was not initially designed to study stimulant
medication effects, therefore we were not able to study the
effects of different doses of treatment. In addition, treat-
ment histories of patients were solely based on self-report,
which may be vulnerable to biases.
In conclusion, the results presented here provide support for
the hypothesis that alterations in right caudate volume persist
into adulthood in ADHD in males. This gender difference
advocates for gender to be taken into account in future
neuroimaging studies. Caudate volume correlated with beha-
vioral measures of hyperactivity/impulsivity in the male
patients, which may point to different ADHD pathophysiology
in men and women. Depression in ADHD was related to
hippocampal volume reduction, but it has to be clariﬁed
whether effects of current depressive symptoms also exist.
Finally, as brain alterations in children and adults
with ADHD seem not to be restricted to isolated brain
regions in most cases, further studies should also investigate
structural and functional connectivity in neural networks
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